Tag: groups

Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR

The study showed that orelabrutinib was safe and well tolerated in participants with SLE.

FORMULA 1 TO RACE ON THE STREETS OF LAS VEGAS THROUGH 2037

For approved assets, click hereLAS VEGAS, June 4, 2026 /PRNewswire/ -- Formula 1® will continue racing in Las Vegas, the Sports and Entertainment Capital...

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

The intravenous part of the Phase IIb clinical dose-finding trial PROCEED met its primary endpoint, with bocunebart demonstrating a statistically significant reduction in monthly...

Communication Service for the Deaf Appoints Karen Peltz Strauss to Board of Directors

AUSTIN, Texas, June 4, 2026 /PRNewswire/ -- Communication Service for the Deaf (CSD) announced today that it has appointed Karen Peltz Strauss to its...

Imagination Meets Innovation at NCTC and ACA Connects’ The Independent Show 2026 in Walt Disney World

NCTC and ACA Connects bring independent broadband leaders to Disney for TIS 2026, featuring AI, mobile, policy and network innovation.

CIQ expands Fuzzball to full multi-cloud so AI and HPC teams ship faster and spend less, with absolute workflow reproducibility and portability

Fuzzball intelligently meta-orchestrates AI and HPC workloads across CoreWeave, AWS, GCP, OCI, Azure and on-premises infrastructure from one control planeRENO, Nev., June 4, 2026...

Minister Hajdu and industry leaders launch the Mining and Minerals Workforce Alliance

WESTERN SHORE, NS, June 4, 2026 /CNW/ - As Canada's labour market continues to face sustained pressures from tariffs, skills shortages, supply chain disruptions,...

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

Colorado student advances to national finals of the Mott Million Dollar Challenge in Flint, Michigan

Sierra Achieves FedRAMP High Certification Through Partnership with Knox Systems

“Mr. Wine of Texas” Bob Landon Breaks Down Wine Aromas for HelloNation

Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR

FORMULA 1 TO RACE ON THE STREETS OF LAS VEGAS THROUGH 2037

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

Communication Service for the Deaf Appoints Karen Peltz Strauss to Board of Directors

Imagination Meets Innovation at NCTC and ACA Connects’ The Independent Show 2026 in Walt Disney World

CIQ expands Fuzzball to full multi-cloud so AI and HPC teams ship faster and spend less, with absolute workflow reproducibility and portability

Minister Hajdu and industry leaders launch the Mining and Minerals Workforce Alliance

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

Papa Murphy’s Launches “Summer Selects” Pizza Deals to Make Summer Meals Easy, Delicious and Budget-Friendly

Justice Necessary launches HygienePalooza, a statewide tour to bring hygiene essentials to Colorado students

Slick City Action Park Names Josh Cole Chief Marketing Officer

It’s Not a Prenatal Class, It’s a Social Club With a Curriculum for Parenthood — Launching in Miami This August

Explore

Press Releases

News & Opinion

Living

Others

Follow us